BiotechTube
VIDA Diagnostics

VIDA Diagnostics

Coralville, United States· Est.
vidalung.ai
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $46M

Overview

VIDA Diagnostics operates at the intersection of AI, medical imaging, and clinical trials, offering a platform and services to improve the efficiency and quality of imaging data in drug development. Founded in 2007 and based in Coralville, Iowa, the company has established a strong foundation in respiratory disease biomarkers and is rapidly expanding its AI algorithms into new therapeutic areas. By providing standardized, quantitative imaging endpoints, VIDA aims to reduce trial risk, enable smaller or faster studies, and support the approval of novel therapies.

RespiratoryCardiovascularOncologyNeurologyMusculoskeletalGastroenterology

Technology Platform

VIDA Intelligence Platform: A cloud-based, AI-powered platform for clinical trial imaging. It manages image data acquisition, site operations, and provides quantitative digital biomarker analysis from CT, MRI, and PET scans across multiple disease areas.

Funding History

3
Total raised:$46M
Series C$15M
Series B$20M
Series A$11M

Opportunities

The 700% growth in imaging biomarker utilization creates massive demand for standardized, quantitative analysis.
Expansion into large therapeutic areas like oncology and cardiovascular represents a significant addressable market extension.
The ability to create external control arms from its digital biobank offers a novel service that can reduce trial size, cost, and duration for sponsors.

Risk Factors

Faces competition from large imaging CROs and numerous AI-medical imaging startups.
Regulatory acceptance of novel digital biomarkers as primary endpoints is a lengthy and uncertain process.
Revenue is likely dependent on the clinical trial spending cycles of a concentrated set of biopharma clients.

Competitive Landscape

VIDA competes with large, full-service Contract Research Organizations (CROs) with imaging divisions (e.g., Clario, IQVIA), specialized imaging CROs, and a growing array of venture-backed AI imaging software companies. Its differentiation lies in its integrated platform combining AI biomarkers, site operations tools, and a curated data repository for trial design.

More companies in Diagnostics & Precision Medicine →More companies in United States →